Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live attenuated herpes zoster vaccine phase 3 trial in adults ≥40 years
CTR20170598Phase 3Active
- Sponsor
- Changchun Changsheng Biotechnology
- Start
- Oct 2017
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by Changchun Changsheng Biotechnology. Started Oct 2017; status: active.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20170598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170598.